Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)

NCT02611713 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02611713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02611713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
January 4, 2016
Completion date
December 24, 2020
Enrollment
213 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

advanced parkinson's disease